A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma

References

• Batchelor T, Loeffler J S. Primary CNS lymphoma. J Clin Oncol 2006; 24: 1281–1288
   PubMed Web of Science ®Google Scholar
• Abrey L E, DeAngelis L M, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859–863
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Yahalom J, Thaler H T, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635–643
   PubMed Web of Science ®Google Scholar
• Glass J, Gruber M L, Cher L, Hochberg F H. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994; 81: 188–195
   PubMed Web of Science ®Google Scholar
• Abrey L E, Yahalom J, DeAngelis L M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
   PubMed Web of Science ®Google Scholar
• Gavrilovic I T, Hormigo A, Yahalom J, DeAngelis L M, Abrey L E. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 2006; 24: 4570–4574
   PubMed Web of Science ®Google Scholar
• Abrey L E, Batchelor T T, Ferreri A J, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005; 23: 5034–5043
   PubMed Web of Science ®Google Scholar
• O'Brien P, Roos D, Pratt G, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000; 18: 519–526
   PubMed Web of Science ®Google Scholar
• O'Brien P C, Roos D E, Pratt G, et al. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a phase II multicenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys 2006; 64: 408–413
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Yahalom J, Heinemann M H, Cirrincione C, Thaler H T, Krol G. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 1990; 40: 80–86
   PubMed Web of Science ®Google Scholar
• Laperriere N J, Cerezo L, Milosevic M F, Wong C S, Patterson B, Panzarella T. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother Oncol 1997; 43: 247–252
   PubMed Web of Science ®Google Scholar
• Nelson D F, Martz K L, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9–17
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Ogino H, Hasegawa M, et al. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Int J Radiat Oncol Biol Phys 2005; 62: 809–813
   PubMed Web of Science ®Google Scholar
• Blay J Y, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998; 16: 864–871
   PubMed Web of Science ®Google Scholar
• Omuro A M, DeAngelis L M, Yahalom J, Abrey L E. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Neurology 2005; 64: 69–74
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Seiferheld W, Schold S C, Fisher B, Schultz C J. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93–10. J Clin Oncol 2002; 20: 4643–4648
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Reni M, Dell'Oro S, et al. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients. Oncology 2001; 60: 134–140
   PubMed Web of Science ®Google Scholar
• Poortmans P M, Kluin-Nelemans H C, Haaxma-Reiche H, et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol 2003; 21: 4483–4488
   PubMed Web of Science ®Google Scholar
• Pels H, Schmidt-Wolf I G, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003; 21: 4489–4495
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Kuker W, Uhl M, et al. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. Ann Neurol 2005; 57: 843–847
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Schabet M, Brugger W, et al. German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 2002; 51: 247–252
   PubMed Web of Science ®Google Scholar
• Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003; 21: 1044–1049
   PubMed Web of Science ®Google Scholar
• Guha-Thakurta N, Damek D, Pollack C, Hochberg F H. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients. J Neurooncol 1999; 43: 259–268
   PubMed Web of Science ®Google Scholar
• Calderoni A, Aebi S. Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas. J Neurooncol 2002; 59: 227–230
   PubMed Web of Science ®Google Scholar
• Feuerhake F, Baumer C, Cyron D, et al. Primary CNS lymphoma in immunocompetent patients from 1989 to 2001: a retrospective analysis of 164 cases uniformly diagnosed by stereotactic biopsy. Acta Neurochir (Wien) 2006; 148: 831–838, discussion 838
   PubMed Web of Science ®Google Scholar
• Freilich R J, Delattre J Y, Monjour A, DeAngelis L M. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46: 435–439
   PubMed Web of Science ®Google Scholar
• Hodson D J, Bowles K M, Cooke L J, et al. Primary central nervous system lymphoma: a single-centre experience of 55 unselected cases. Clin Oncol (R Coll Radiol) 2005; 17: 185–191
   PubMed Web of Science ®Google Scholar
• Ng S, Rosenthal M A, Ashley D, Cher L. High-dose methotrexate for primary CNS lymphoma in the elderly. Neuro Oncol 2000; 2: 40–44
   PubMed Web of Science ®Google Scholar
• Silvani A, Salmaggi A, Eoli M, et al. Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience. J Neurooncol 2007; 82: 273–279
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 2002; 58: 1513–1520
   PubMed Web of Science ®Google Scholar